Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 1, 2019

Study Completion Date

November 1, 2019

Conditions
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Interventions
DRUG

Vofatamab

DRUG

Docetaxel

DRUG

Placebo

Trial Locations (65)

110

Research Site, Taipei

333

Research Site, Taoyuan District

435

Research Site, Taichung

704

Research Site, Tainan City

11217

Research Site, Taipei

12808

Research Site, Prague

13210

Research Site, Syracuse

13620

Research Site, Seongnam-si

16059

Research Site, Bursa

18014

Research Site, Granada

20132

Research Site, Milan

20133

Research Site, Milan

20141

Research Site, Milan

22030

Research Site, Edirne

27003

Research Site, Lugo

28007

Research Site, Madrid

28033

Research Site, Madrid

28041

Research Site, Madrid

28046

Research Site, Madrid

28050

Research Site, Madrid

31008

Research Site, Pamplona

33011

Research Site, Oviedo

33140

Research Site, Miami

34732

Research Site, Istanbul

35340

Research Site, Izmir

36204

Research Site, Vigo

37024

Research Site, Negrar

40202

Research Site, Louisville

40447

Research Site, Taichung

41124

Research Site, Modena

44280

Research Site, Malatya

46009

Research Site, Valencia

46845

Reaserach Site, Fort Wayne

48201

Research Site, Detroit

53100

Research Site, Siena

55905

Research Site, Rochester

60126

Research Site, Ancona

61469

Research Site, Gwangju

77900

Research Site, Olomouc

80131

Research Site, Napoli

81362

Research Site, Kaohsiung City

83301

Research Site, Kaohsiung City

85234

Research Site, Gilbert

85338

Research Site, Goodyear

91010

Research Site, Duarte

95123

Research Site, Catania

02215

Research Site, Boston

75390-9110

Research Site, Dallas

405-760

Research Site, Incheon

02841

Research Site, Seoul

03080

Research Site, Seoul

03722

Research Site, Seoul

05505

Research Site, Seoul

06351

Research Site, Seoul

08916

Research Site, Badalona

08003

Research Site, Barcelona

08026

Research Site, Barcelona

08036

Research Site, Barcelona

08908

Research Site, Barcelona

751 85

Research Site, Uppsala

01330

Research Site, Adana

06590

Research Site, Ankara

07059

Research Site, Antalya

SW36JJ

Research Site, London

PR29HT

Research Site, Preston

Sponsors
All Listed Sponsors
lead

Rainier Therapeutics

INDUSTRY